60 Degrees Pharmaceuticals, Inc.
SXTP · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | -$0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 333.6% | -38.3% | -37.4% | – |
| Gross Profit | -$0 | $0 | $0 | $0 |
| % Margin | -22.9% | 50.4% | 55.2% | 54.8% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -523.8% | -1,696.7% | -1,136.4% | -777.3% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -529.5% | -1,717.7% | -1,147.4% | -783.6% |
| EPS Diluted | -0.66 | -1.25 | -1.56 | -4.5 |
| % Growth | 47.2% | 19.9% | 65.3% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |